{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:10:09Z","timestamp":1790403009926,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:00:00Z","timestamp":1614988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:00:00Z","timestamp":1614988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is currently a lack of information on full anogenital evaluation of women with a previous history of anogenital neoplasia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective analysis of the Homerton Anogenital Neoplasia Service records from January 2012 to March 2017, to identify all new referrals of women with previous anogenital neoplasia, who had had at least one complete examination of all anogenital sites. Multizonal anogenital disease (MZD) was defined as the presence of high-grade squamous intraepithelial lesions (HSIL)\/carcinoma concurrently at two or more of the following sites\/zones: perianus, anal canal, vulva, vagina or cervix.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>253 women were included, mean age was 47 (SD=15) years and median duration of follow-up was 12 (IQR=21) months. Fifty-six women (22%) were diagnosed with MZD at first assessment and\/or during follow-up. Current smokers (RR=1.84, 95% CI 1.21\u20132.79, p=0.004) and women on immunodulators\/immunosuppressive drugs (RR=2.57, 95% CI 1.72-3.86, p&lt;0.001) had an increased risk for MZD. The risk was lower for women without a previous history of anogenital high-grade lesions\/cancer compared to those with this history (RR=0.06, 95% CI 0.01-0.45, <jats:italic>p<\/jats:italic>=0.006).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Multizonal assessment was important to diagnose occult areas of disease and should be especially considered in current smokers, pharmacologically immunocompromised and those with a previous history of anogenital HSIL\/cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-07949-8","type":"journal-article","created":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T18:03:05Z","timestamp":1615053785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Multizonal anogenital neoplasia in women: a cohort analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Andreia","family":"Albuquerque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A. L.","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelina","family":"Cappello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pesola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bowring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamzin","family":"Cuming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"De Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam N.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sasieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayura","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,6]]},"reference":[{"key":"7949_CR1","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/ijc.24116","volume":"124","author":"H De Vuyst","year":"2009","unstructured":"De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124:1626\u201336.","journal-title":"Int J Cancer"},{"key":"7949_CR2","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/0140-6736(92)92961-E","volume":"340","author":"JH Scholefield","year":"1992","unstructured":"Scholefield JH, Hickson WG, Smith JH, Rogers K, Sharp F. Anal intraepithelial neoplasia: part of a multifocal disease process. Lancet. 1992;340:1271\u20133.","journal-title":"Lancet"},{"key":"7949_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/0140-6736(91)91233-K","volume":"338","author":"M Melbye","year":"1991","unstructured":"Melbye M, Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet. 1991;338:657\u20139.","journal-title":"Lancet"},{"key":"7949_CR4","doi-asserted-by":"publisher","first-page":"115.e111","DOI":"10.1016\/j.ajog.2011.03.011","volume":"205","author":"CM Jacyntho","year":"2011","unstructured":"Jacyntho CM, Giraldo PC, Horta AA, Grandelle R, Gon\u00e7alves AK, Fonseca T, et al. Association between genital intraepithelial lesions and anal squamous intraepithelial lesions in HIV-negative women. Am J Obstet Gynecol. 2011;205:115.e111\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"7949_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1470-2045(07)70043-8","volume":"8","author":"G Edgren","year":"2007","unstructured":"Edgren G, Spar\u00e9n P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol. 2007;8:311\u20136.","journal-title":"Lancet Oncol"},{"key":"7949_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00001648-200007000-00016","volume":"11","author":"K Hemminki","year":"2000","unstructured":"Hemminki K, Dong C, Vaittinen P. Second primary cancer after in situ and invasive cervical cancer. Epidemiology. 2000;11:457\u201361.","journal-title":"Epidemiology"},{"key":"7949_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ygyno.2009.05.006","volume":"114","author":"W Jim\u00e9nez","year":"2009","unstructured":"Jim\u00e9nez W, Paszat L, Kupets R, Wilton A, Tinmouth J. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Gynecol Oncol. 2009;114:395\u20138.","journal-title":"Gynecol Oncol"},{"key":"7949_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/DCR.0b013e3182061b34","volume":"54","author":"DC Koppe","year":"2011","unstructured":"Koppe DC, Bandeira CB, Rosa MR, Cambruzzi E, Meurer L, Fagundes RB. Prevalence of anal intraepithelial neoplasia in women with genital neoplasia. Dis Colon Rectum. 2011;54:442\u20135.","journal-title":"Dis Colon Rectum"},{"key":"7949_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0090-8258(03)00231-2","volume":"90","author":"HS Evans","year":"2003","unstructured":"Evans HS, Newnham A, Hodgson SV, M\u00f8ller H. Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England. Gynecol Oncol. 2003;90:131\u20136.","journal-title":"Gynecol Oncol"},{"key":"7949_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/AOG.0b013e31820bfb16","volume":"117","author":"AM Saleem","year":"2011","unstructured":"Saleem AM, Paulus JK, Shapter AP, Baxter NN, Roberts PL, Ricciardi R. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol. 2011;117:643\u20139.","journal-title":"Obstet Gynecol"},{"key":"7949_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","volume":"16","author":"TM Darragh","year":"2012","unstructured":"Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, et al. Members of LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16:205\u201342.","journal-title":"J Low Genit Tract Dis"},{"key":"7949_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","volume":"17","author":"LS Massad","year":"2013","unstructured":"Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17:S1\u2013S27.","journal-title":"J Low Genit Tract Dis"},{"key":"7949_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41416-018-0273-9","volume":"120","author":"DC Gilbert","year":"2019","unstructured":"Gilbert DC, Wakeham K, Langley RE, Vale CL. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis. BJC. 2019;120:256\u201368.","journal-title":"BJC"},{"key":"7949_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/LGT.0b013e31825d2d7a","volume":"16","author":"S Tatti","year":"2012","unstructured":"Tatti S, Suzuki V, Fleider L, Maldonado V, Caruso R, Tinnirello ML. Anal intraepithelial lesions in women with human papillomavirus-related disease. J Low Genit Tract Dis. 2012;16:454\u20139.","journal-title":"J Low Genit Tract Dis"},{"key":"7949_CR15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/AOG.0b013e3181ea1834","volume":"116","author":"JT Santoso","year":"2010","unstructured":"Santoso JT, Long M, Crigger M, Wan JY, Haefner HK. Anal intraepithelial neoplasia in women with genital intraepithelial neoplasia. Obstet Gynecol. 2010;116:578\u201382.","journal-title":"Obstet Gynecol"},{"issue":"3 Suppl 1","key":"7949_CR16","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/LGT.0000000000000117","volume":"19","author":"AB Moscicki","year":"2015","unstructured":"Moscicki AB, Darragh TM, Berry-Lawhorn JM, Roberts JM, Khan MJ, Boardman LA, et al. Screening for Anal Cancer in Women. J Low Genit Tract Dis. 2015;19(3 Suppl 1):S27\u201342.","journal-title":"J Low Genit Tract Dis."},{"key":"7949_CR17","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1097\/QAD.0000000000000227","volume":"28","author":"O Richel","year":"2014","unstructured":"Richel O, Prins JM, de Vries HJ. Screening for anal cancer precursors: what is the learning curve for high-resolution anoscopy? AIDS. 2014;28:1376\u20137.","journal-title":"AIDS."},{"key":"7949_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12885-018-4475-6","volume":"18","author":"A De-Masi","year":"2018","unstructured":"De-Masi A, Davis E, Cuming T, Chindawi N, Pesola F, Cappello C, et al. The acceptability of high resolution anoscopy examination in patients attending a tertiary referral centre. BMC Cancer. 2018;18:554.","journal-title":"BMC Cancer."},{"key":"7949_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/oxfordjournals.aje.a116270","volume":"135","author":"JR Daling","year":"1992","unstructured":"Daling JR, Sherman KJ, Hislop TG, Maden C, Mandelson MT, Beckmann AM, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol. 1992;135:180\u20139.","journal-title":"Am J Epidemiol"},{"key":"7949_CR20","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/bjc.2017.370","volume":"117","author":"A Albuquerque","year":"2017","unstructured":"Albuquerque A, Pessegueiro Miranda H, Lopes J, Gandara J, Rodrigues S, Gaspar R, et al. Liver transplanted recipients have a higher prevalence of anal squamous intraepithelial lesions. Br J Cancer. 2017;117:1761\u20137.","journal-title":"Br J Cancer"},{"key":"7949_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/cid\/ciw729","volume":"64","author":"M Gaisa","year":"2017","unstructured":"Gaisa M, Ita-Nagy F, Sigel K, Arens Y, Hennessy MA, Rodriguez-Caprio G, et al. High Rates of anal high-grade squamous intraepithelial lesions in HIV-infected women who do not meet screening guidelines. Clin Infect Dis. 2017;64:289\u201394.","journal-title":"Clin Infect Dis"},{"key":"7949_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJM198710153171601","volume":"317","author":"JR Daling","year":"1987","unstructured":"Daling JR, Weiss NS, Hislop TG, Maden C, Coates RJ, Sherman KJ, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987;317:973\u20137.","journal-title":"N Engl J Med"},{"key":"7949_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59\u201367.","journal-title":"Lancet"},{"key":"7949_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jnma.2020.03.002","volume":"112","author":"A Buskwofie","year":"2020","unstructured":"Buskwofie A, David-West G, Clare CA. A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc. 2020;112:229\u201332.","journal-title":"J Natl Med Assoc."},{"key":"7949_CR25","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.jaad.2019.07.055","volume":"81","author":"A Tan","year":"2019","unstructured":"Tan A, Bieber AK, Stein JA, Pomeranz MK. Diagnosis and management of vulvar cancer: A review. J Am Acad Dermatol. 2019;81:1387\u201396.","journal-title":"J Am Acad Dermatol."},{"key":"7949_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/ijc.33185","volume":"148","author":"G Clifford","year":"2021","unstructured":"Clifford G, George D, Shiels MS, Engels E, Albuquerque A, Poynten M, Pokomandy A, et al. A meta-analysis of anal cancer incidence by risk group: towards a unified anal cancer risk scale. Int J Cancer. 2021;148:38\u201347.","journal-title":"Int J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-021-07949-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T18:05:58Z","timestamp":1615053958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-07949-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,6]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7949"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-07949-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,6]]},"assertion":[{"value":"25 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Health Research Authority approved this study (IRAS number 229262) after the London - Surrey Borders Research Ethics Committee approval (17\/LO\/1159). All methods were performed in accordance with the relevant guidelines and regulations. Informed consent was waived off, this was a retrospective study of existing data. Any patient that has explicitly expressed dissent in his\/her clinical consent form in their medical records that did not wish for their records to be used for research purposes were not included in this study. Informed consent was waived off by the London - Surrey Borders Research Ethics Committee, this was a retrospective study of existing data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this manuscript have no conflicts of interest to disclose related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}